Targeted biological therapies have transformed the treatment of blood cancers and autoimmune disorders. RITUXIREL 500 Injection is a widely used monoclonal antibody known for its effectiveness and safety profile. At Unnati Pharmax, we specialize in the export of RITUXIREL 500 from India, supplying high-quality pharmaceutical products to global markets.
This blog provides complete information about RITUXIREL 500 uses, mechanism, dosage, safety, and export availability, helping buyers and healthcare professionals make informed decisions.
What is RITUXIREL 500 Injection?
RITUXIREL 500 is a branded formulation of Rituximab 500 mg, a monoclonal antibody that targets the CD20 antigen present on B-cells. By binding to these cells, it helps in destroying abnormal or overactive B-cells.
As a result, RITUXIREL 500 is effective in treating certain cancers and immune-related conditions.
Uses of RITUXIREL 500 Injection
RITUXIREL 500 is commonly prescribed for:
-
Non-Hodgkinβs Lymphoma
-
Chronic Lymphocytic Leukemia (CLL)
-
Rheumatoid Arthritis
-
Certain autoimmune and inflammatory disorders
-
Combination chemotherapy regimens
Therefore, RITUXIREL 500 plays a critical role in both oncology and immunology treatments.
How Does RITUXIREL 500 Work?
RITUXIREL 500 contains Rituximab, which binds to CD20-positive B-cells.
Consequently:
-
Abnormal B-cells are destroyed
-
Disease progression slows
-
Immune balance is restored
This targeted action improves treatment effectiveness while minimizing damage to healthy cells.
Dosage and Administration
-
RITUXIREL 500 is administered intravenously (IV)
-
Dosage depends on:
-
Patientβs body surface area
-
Disease type and severity
-
Treatment protocol
-
β οΈ Important: Administration must be done by trained healthcare professionals in a controlled clinical setting.
Possible Side Effects
Some patients may experience:
-
Fever or chills during infusion
-
Fatigue
-
Nausea
-
Low blood cell counts
-
Infections (due to immune suppression)
However, patients are closely monitored to manage side effects effectively.
Precautions and Warnings
Before using RITUXIREL 500, patients should inform their doctor if they have:
-
Active infections
-
Heart or lung disease
-
Hepatitis B history
Additionally, pre-medication is often recommended to reduce infusion reactions.
Why Choose Unnati Pharmax for RITUXIREL 500 Export?
Unnati Pharmax is a trusted pharmaceutical exporter from India, recognized for quality and regulatory compliance.
Our Key Advantages
-
WHO-GMP certified manufacturers
-
Competitive export pricing
-
Cold-chain compliant packaging
-
Complete export documentation
-
Reliable worldwide delivery
As a result, international buyers choose Unnati Pharmax for biologic medicine supply.
Global Export of RITUXIREL 500 Injection
Unnati Pharmax exports RITUXIREL 500 to:
-
Africa
-
Middle East
-
Southeast Asia
-
CIS countries
-
Latin America
Moreover, we support buyers with regulatory and logistics assistance for smooth import clearance.
Frequently Asked Questions (FAQs)
1. What is RITUXIREL 500 Injection used for?
RITUXIREL 500 is used to treat lymphomas, leukemia, rheumatoid arthritis, and autoimmune disorders.
2. Is RITUXIREL 500 chemotherapy?
No. RITUXIREL 500 is a targeted monoclonal antibody therapy, not traditional chemotherapy.
3. Can RITUXIREL 500 be exported from India?
Yes. Unnati Pharmax exports RITUXIREL 500 with full legal and regulatory documentation.
4. How should RITUXIREL 500 be stored?
Store under refrigerated conditions as specified on the product label.
5. Why buy RITUXIREL 500 from Unnati Pharmax?
Because we offer authentic products, export expertise, and dependable global supply.
Conclusion
In conclusion, RITUXIREL 500 Injection is a highly effective targeted therapy for cancer and autoimmune diseases. Choosing a reliable exporter is essential for quality and continuity of treatment.